TSX News -
Spectral Announces Publication of the post hoc analysis of EUPHRATES trial in Intensive Care Medicine
TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT), a Phase III company developing […]